The back records of the time of their angioplasty (at time of presentation) were tracked and referred. Average age of the study population was found to be 58.7 years (SD: 9.2 years, ranging 29-79 years, comprising 97 males and 39 females). Mean age of patients with ST and ISR requiring TLR was 61.8 years and without stent restenosis was 58.3 years. All 7 patients who had ISR were suffering from diabetes and hypertension. Association between diabetes and ISR (Chi square = 5.488; p = 0.01; considering 95% CI) and hypertension & ISR (Chi square = 6.756; p = 0.00) is significant. While comparing the two stents: everolimus-eluting and sirolimus-eluting coronary stents with the outcome, i.e., in-stent restenosis and target lesion revascularization (Chi square = 0.005; p = 0.94) with 95% CI, no significant difference between the two stents was found. Hence the null hypothesis, that there is no significant difference between use of everolimus-eluting and sirolimus-eluting coronary stents on clinical and angiographic follow-up is accepted. Therefore EES implantation was non-inferior to and had similar results to SES implantation after one year in terms of clinical and angiographic outcome. Both the SES and EES groups showed a similar efficacy and excellent outcome after one year with a very low rate of in-stent restenosis, stent thrombosis, and target-lesion revascularization.
Non-right coronary sinus origin right coronary artery intervention: Our experience over 3 years
Arindam Pande *, Rabin Chakraborty Apollo Gleneagles Hospital, Kolkata, India Non-right coronary sinus origin RCA interventions are technically demanding. Proper selection of hardware is the key to success. Over last 3 years we had total 16 such interventions (7 RCA from left coronary sinus and 9 from non-coronary sinus). RCA from Leftcoronary cusp were more difficult to engage than non-coronary cusp. Mean fluoroscopic time (22.6 min [11.6-66 .5] vs 16.5 min [13.4-38.6 ]) as well as mean volume of contrast used (206 ml [112-322] vs 168 ml ) were both higher in left coronary sinus origin RCA interventions. In our series, RCA from non-coronary cusp were most frequently engaged with AR guiding catheter whereas RCA from left-coronary cusp were most frequently engaged with JL guiding catheter.
Bioresorbable scaffolds for coronary artery in-stent restenosis
Arindam Pande *, Rabin Chakraborty Apollo Gleneagles Hospital, Kolkata, India Introduction: Management of coronary artery in-stent restenosis (ISR) is a challenging as well as debatable topic. Options include plain old balloon angioplasty (POBA), metallic stent, cutting or scoring balloon and drug-eluting balloon (DEB). All the techniques have their own advantages and drawbacks. Till date the optimum treatment strategy is undefined. Methods and results: In the current series we implanted five bioresorbable vascular scaffolds (BVS) in ISR over a period of 1 year. Most of the procedures were guided by intravascular imaging (OCT in 2 cases and IVUS in 1 case). The patients were followed up subsequently (for a mean period of 5 months). All the patients were symptom free till date. No repeat target vessel revascularization had to be performed. Discussion: BVS is the latest advance in the armamentarium of interventional therapies for treating de novo significant coronary artery disease. Recent data from trials have suggested many advantages of BVS over DES. The rationale of using BVS in ISR is based on the concept of local drug delivery as achieved by DEB with the benefits of a scaffold to stabilize dissection flaps, and prevent acute recoil as provided by metallic stent, without the permanent bi-layer of metal, that in some vessels, may in and by itself create flow abnormality. Conclusion: BVS based treatment strategy for ISR have appealing biologic advantage. Efficacy and outcomes of this new therapeutic option need to be evaluated in comparison to other established PCI based therapies, such as repeat metallic stent implantation, in a randomized setting.
An interesting case report of coronary artery perforation following PCI M. Sadiq Azam *, P.A. Jiwani Background: Coronary artery perforation is a rare complication of PCI with a reported incidence of 0.2-0.6%. Development of pericardial tamponade has been associated with a high mortality. We present a report of one such patient highlighting the key learning points from the case. Case Report: A 69-year-old male admitted with a history of angina equivalent since 2 months, CAG done revealed significant proximal LAD complex bifurcation lesion. PTCA/stent to mid to distal LAD was done using 3.0-2.5 mm Â 60 mm BIOMIME MORPH DES. Post-stenting patient developed sudden hypotension and asystole. Angiogram revealed coronary leak with dye staining of pericardial sac and 2D Echo showed gross pericardial fluid collection suggestive of tamponade. Pericardiocentesis was done via pigtail catheter and the aspirated blood was autotransfused via the femoral vein. Patient was intubated, started on inotropes. His vitals stabilized transiently but within minutes patient once again became hypotensive and developed bradycardia. Echo revealed gross reaccumulation of pericardial fluid. Pericardiocentesis and autotransfusion was done repeatedly. CAG revealed a persistent significant leak from the mid part of the LAD stent. A 3 mm Â 16 mm coronary covered stent was placed in stent in the mid-LAD, which effectively sealed the leak. Pericardiocentesis and auto transfusion was repeated post procedure. Patient was stabilized and shifted to ICCU. Serial repeat 2D Echo did not reveal any reaccumulation of fluid in pericardial sac. Patient was on ventilator for 72 h due to neurological impairment and was started on neuroprotective agents by neurophysician. He showed gradual improvement, was extubated and shifted to the ward after 7 days in ICU. With regular physiotherapy, rehabilitation and optimal medications, patient recovered well with minimal residual neurological deficit. He was discharged after 15 days and is hemodynamically stable on regular follow-up. Conclusion: Pericardial tamponade due to coronary artery perforation has a high mortality. Surgical intervention has been cited as the only life-saving option in such cases. Expertise in the use of covered stents may provide a quick and valuable rescue option for this serious complication.
A single center experience of device closure for ventricular septal rupture in acute myocardial infarction 
(AMI). Survival to 1 month without intervention is 6%. Surgical patch repair has a high mortality of 47% in the first 30 days after closure. Due to the high mortality rate, the use of percutaneous occluders, have been investigated. There is very scant data on device closure of VSR post AMI from India and hence we are presenting our single center experience in 7 patients with percutaneous closure of post-MI VSR using the Amplatzer occluder device. Method: Device closure for VSR after acute MI has been attempted at our center since December 2005. We analyzed the case records available from the first case in December 2005 until June 2015. Data were collected regarding patient demographics, clinical features, pre-procedural clinical condition, echocardiographic features, procedural characteristics, procedural complications, in-hospital outcomes, and vital status. Results: Our series comprises of 7 cases (4 females and 3 males). The mean age was 58.29 AE 9.8 years. 5 patients had an anterior wall MI and 2 had an inferior wall MI. None of the patients received thrombolytic therapy. 4 patients had cardiogenic shock on presentation. IABP was placed in all patients; in addition 1 required CRRT and 1 required TPI. All patients underwent primary closure of the VSR. Device was successfully placed in 5 patients (71.4%) with minimal residual shunt in 2 patients (40%). All patients with anterior wall MI had a successful device placement and both patients with inferior wall MI did not survive. 2 patients of the 7 survived to discharge (29%), 3 patients with cardiogenic shock expired (75%). The 2 patients who survived are doing well on regular follow-up. Conclusion: Device closure of a post MI VSR continues to be a lesson in learning. However, it is a promising method that when successful can offer patients who are at high risk for surgery a fresh lease of life. Background: Percutaneous cannulation of the radial and femoral artery has proven to be a useful approach to the performance of diagnostic and interventional coronary procedures. However, need of radial artery as graft vessel for coronary artery bypass surgery (CABG) in future and failure to access radial artery due to anatomical variation, prompts one to switch for femoral route. Ulnar artery cannulation for operators expert in radial intervention provide the opportunity to save radial artery for future and switch to ulnar rather than complication prove femoral route. Here we are providing simple bedside clinical score for prediction of success of ulnar artery cannulation. Methods: Ulnar artery was cannulated for coronary angiography in 1187 patients from June 2011-April 2014 undergoing coronary angiography. Data collection included: number of attempts needed to cannulated ulnar artery (failure if ≥3 attempts), volume of pulse (good volume: pulse pressure > 40 mmHg), experience of the operator (>50 radial/ulnar cannulation versus <50 cannulation), palpability of ulnar artery with ease (when compared to radial artery), calcification of vessel present or not, tortuosity of vessel and sex category. Data was collected with intention to construct a model for predicting successful outcome for ulnar artery cannulation procedure. Results: Outcomes were analyzed running fit model on JMP SAS software version 11.2.0. Results were displayed as regression plot, leverage plot (for better visualization of the influence of points on the test for including the effect in the model) and actual by predicted plot. Confidence curves for the line of fit suggested the test of interest is significant at the 5% level. Plot yielded Rsquare value of 0.919 (with Rsquare adjusted: 0.899). The PRESS (prediction error sum of squares) statistic was run to compare different model depending on inclusion of different parameters, the model containing five parameter (Volume, Inability to palpate with ease, Tortuosity, Experience of operator and Calcification with score 1 for each parameter: VInTEC model) resulted in least score, suggesting best-fit model. The lack of fit report showed Prob > F value, indicating non significant lack of fit error. On random sample of 100 patients intravariability and intervariability was tested was 0.21 and 0.27, respectively. Best C statistics value was achieved for cutoff of score 3. Conclusion: Ulnar's VImTEC score ≤3 is a simple and easy bedside score that can predict for the successful cannulation of ulnar artery.
Transulnar versus transradial access as a default strategy for percutaneous coronary intervention: AJULAR cohort Background: Percutaneous coronary interventions (PCI) are undergoing a paradigm shift from femoral to forearm approach due to obvious advantages in terms of patient safety, comfort and faster ambulation. Transradial access (TRA) has been established as a primary forearm access site. Use of transulnar access (TUA) as an alternative to radial route can serve as a novel optional forearm access to the interventionalists. Aim: To evaluate TUA versus TRA access as a default strategy for PCI. Methods: This was a prospective, single center randomized controlled trial involving 2300 patients, of whom 220 underwent PCI in 1:1 randomization to TUA (n = 110) or TRA (n = 110). Primary endpoint was composite of major adverse cardiac events (MACE) during hospital stay, cross-over to another arterial site, major vascular events of the arm during hospital stay (large hematoma with hemoglobin drop of ≥5 gm%) and occlusion rate. Secondary endpoints were individual components of primary endpoint and spasm of the vessel. Results: Two groups did not differ in baseline characteristics. On intention to treat (ITT) analysis, primary end point occurred in 10.91% of TUA and 12.73% of TRA arm (OR: 0.84; 95% confidence interval [CI] , 0.37-1.91; p value = 0.68 at a = 0.05). Further on per protocol (PP) analysis, primary end point occurred in 9.21% of TUA and 11.11% of TRA arm (OR: 0.81; 95% confidence interval [CI], 0.29-2.30; p value = 0.68 at a = 0.05). Secondary endpoints also did not differ significantly between the two groups in ITT and PP analysis. Conclusions: TUA is an excellent alternative to TRA, while performing PCI when performed by an experienced operator. When utilized as an option, TUA increases the chance of success with forearm access and reduces the need for cross over to femoral route.
